North Carolina State University, College of Veterinary Medicine, 1060 William Moore Drive, Raleigh, NC 27607, USA.
Brown University, Department of Pathology and Laboratory Medicine, 70 Ship St., Rm. 522, Providence, RI 02912, USA.
Neurotoxicology. 2018 Jan;64:291-299. doi: 10.1016/j.neuro.2017.10.002. Epub 2017 Oct 8.
It has been suggested that childhood exposure to neurotoxicants may increase the risk of Parkinson's disease (PD) or other neurodegenerative disease in adults. Some recessive forms of PD have been linked to loss-of-function mutations in the Park2 gene that encodes for parkin. The purpose of this pilot study was to evaluate whether responses to neonatal manganese (Mn) exposure differ in mice with a Park2 gene defect (parkin mice) when compared with a wildtype strain (C57BL/6J). Neonatal parkin and C57BL/6J littermates were randomly assigned to 0, 11, or 25mg Mn/kg-day dose groups with oral exposures occurring from postnatal day (PND) 1 through PND 28. Motor activity was measured on PND 19-22 and 29-32. Tissue Mn concentrations were measured in liver, femur, olfactory bulb, frontal cortex, and striatum on PND 29. Hepatic and frontal cortex gene expression of Slc11a2, Slc40a1, Slc30a10, Hamp (liver only), and Park2 were also measured on PND 29. Some strain differences were seen. As expected, decreased hepatic and frontal cortex Park2 expression was seen in the parkin mice when compared with C57BL/6J mice. Untreated parkin mice also had higher liver and femur Mn concentrations when compared with the C57BL/6J mice. Exposure to≥11mg Mn/kg-day was associated with increased brain Mn concentrations in all mice, no strain difference was observed. Manganese exposure in C57Bl6, but not parkin mice, was associated with a negative correlation between striatal Mn concentration and motor activity. Manganese exposure was not associated with changes in frontal cortex gene expression. Decreased hepatic Slc30a10, Slc40a1, and Hamp expression were seen in PND 29 C57BL/6J mice given 25mg Mn/kg-day. In contrast, Mn exposure was only associated with decreased Hamp expression in the parkin mice. Our results suggest that the Parkin gene defect did not increase the susceptibility of neonatal mice to adverse health effects associated with high-dose Mn exposure.
有人认为,儿童时期接触神经毒素可能会增加成年后患帕金森病(PD)或其他神经退行性疾病的风险。一些 PD 的隐性形式与编码 parkin 的 Park2 基因的功能丧失突变有关。本研究的目的是评估在与野生型(C57BL/6J)相比,具有 Park2 基因缺陷(parkin 小鼠)的新生鼠对锰(Mn)暴露的反应是否不同。新生 parkin 和 C57BL/6J 同窝仔鼠被随机分配到 0、11 或 25mg Mn/kg-day 剂量组,从出生后第 1 天(PND)到第 28 天进行口服暴露。在 PND 19-22 和 29-32 测量运动活动。在 PND 29 测量肝、股骨、嗅球、额皮质和纹状体中的组织 Mn 浓度。还在 PND 29 测量肝和额皮质中的 Slc11a2、Slc40a1、Slc30a10、Hamp(仅肝)和 Park2 的基因表达。观察到一些种系差异。如预期的那样,与 C57BL/6J 小鼠相比,parkin 小鼠的肝和额皮质 Park2 表达减少。未经处理的 parkin 小鼠的肝和股骨 Mn 浓度也高于 C57BL/6J 小鼠。暴露于≥11mg Mn/kg-day 与所有小鼠的大脑 Mn 浓度增加有关,未观察到种系差异。在 C57Bl6 中,而不是 parkin 小鼠中,锰暴露与纹状体 Mn 浓度与运动活动之间的负相关有关。锰暴露与额皮质基因表达的变化无关。在给予 25mg Mn/kg-day 的 PND 29 C57BL/6J 小鼠中,观察到肝 Slc30a10、Slc40a1 和 Hamp 表达减少。相比之下,只有在 parkin 小鼠中,Mn 暴露才与 Hamp 表达减少有关。我们的结果表明,Park2 基因缺陷并未增加新生鼠对高剂量 Mn 暴露相关不良健康影响的易感性。